223 related articles for article (PubMed ID: 16532435)
1. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
[TBL] [Abstract][Full Text] [Related]
2. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
5. Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer.
Doi Y; Yashiro M; Yamada N; Amano R; Ohira G; Komoto M; Noda S; Kashiwagi S; Kato Y; Fuyuhiro Y; Hirakawa K
Cancer Sci; 2010 Jun; 101(6):1529-35. PubMed ID: 20367641
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle].
Wang H; Chen G
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):729-32. PubMed ID: 12622916
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
14. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
15. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M
Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
[TBL] [Abstract][Full Text] [Related]
19. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.
Herrmann E; Eltze E; Bierer S; Köpke T; Görge T; Neumann J; Hertle L; Wülfing C
Anticancer Res; 2007; 27(5A):3127-33. PubMed ID: 17970053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
